Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer

Clinical trial NCT04011410 · COMPLETED

Trial details

NCT number: NCT04011410
Sponsor: Patrick Hensley
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Recurrent

Start date: 2019-12-03
Primary completion: 2024-03-08
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.